Larson Financial Group’s Akero Therapeutics AKRO Stock Holding History

Larson Financial Group’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-29	Closed	-$1.38K	–	3459
2025 Q3	$1.38K	Buy	+29	New	+$1.4K	﹤0.01%	2821

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Larson Financial Group's AKRO Position: Q4 2025 in Review

Larson Financial Group sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 29 shares — an estimated $1.38K sold.

Larson Financial Group first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $1.38K in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Larson Financial Group reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Larson Financial Group sold 29 Akero Therapeutics shares in Q4 2025, an estimated $1.38K.
Larson Financial Group first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
Larson Financial Group's Akero Therapeutics position peaked at $1.38K in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Larson Financial Group's 13F filing for Q4 2025, filed 6 Feb 2026.